Tilray Inc (NASDAQ:TLRY - Get Free Report) shares shot up 4.5% on Friday . The company traded as high as $0.46 and last traded at $0.46. 6,080,678 shares traded hands during trading, a decline of 79% from the average session volume of 28,315,347 shares. The stock had previously closed at $0.44.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on TLRY. Piper Sandler dropped their price objective on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a research note on Wednesday, April 9th. Roth Capital reissued a "neutral" rating on shares of Tilray in a research note on Monday, April 14th.
Read Our Latest Research Report on Tilray
Tilray Price Performance
The stock has a market capitalization of $455.84 million, a PE ratio of -1.51 and a beta of 1.95. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. The company's 50 day simple moving average is $0.53 and its 200 day simple moving average is $0.95.
Tilray (NASDAQ:TLRY - Get Free Report) last released its earnings results on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The firm had revenue of $185.78 million during the quarter, compared to analysts' expectations of $213.38 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. On average, equities analysts anticipate that Tilray Inc will post -0.2 earnings per share for the current year.
Institutional Trading of Tilray
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Lido Advisors LLC acquired a new position in shares of Tilray in the 4th quarter valued at $28,000. Verdence Capital Advisors LLC acquired a new position in shares of Tilray in the 4th quarter valued at $29,000. Dudley Capital Management LLC acquired a new position in shares of Tilray in the 4th quarter valued at $29,000. Cerity Partners LLC acquired a new position in shares of Tilray in the 1st quarter valued at $31,000. Finally, Ameritas Advisory Services LLC acquired a new position in shares of Tilray in the 4th quarter valued at $32,000. 9.35% of the stock is owned by hedge funds and other institutional investors.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
